Cannabidiol (CBD), a non-psychoactive compound extract of marijuana, has the potential to be used as an antibiotic. Researchers found CBD was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that are resistant to common antibiotics. Additionally, CBD does not lose its effectiveness after extended treatment.
Researchers report therapies that help change the bacteria in the gut could be beneficial in treating autism.
Antidepressants, such as the SSRI amitriptyline, antibiotics associated with developmental problems and sun cream components are contaminating water, and are being accumulated in fish. Exposure to the medications has effects on the molecular level to the fish. Researchers say this poses a problem as consumption of gilt-head bream is on the rise, and there could be a risk of the contaminants reaching humans via diet.
Zebrafish study finds antibiotics can have detrimental effects on the descendants of those exposed to them, including weaker immune systems.
A new study reveals antibiotics given to pregnant women with Group B Streptococcus during labor can affect a baby's development of gut bacteria.
A new study reports that when minocycline is given to new born rats following a head injury, cognitive deficits are exacerbated.
Gastrointestinal and immune disorders, along with sleep disruptions and seizures often co-occur at similar points of time in those diagnosed under the autism spectrum. Analyzing patterns in diagnosis of co-occurring medical conditions allowed for the identification of three subtypes of children with ASD. The findings could provide new insight into the mechanics of ASD.
FIASMA antidepressants, such as amitriptyline and desipramine, halt the growth of four different kinds of bacterial pathogens in cell cultures and animal models. The antidepressants have shown to be effective in killing intracellular bacteria in two chlamydia infections, as well as human granulocytic anaplasmosis, a tick-borne disease that attacks white blood cells.
Researchers have developed a new antibiotic medication that appears to be safe and effective in treating clostridium difficile infection.
Study reports specific gut bacteria can influence the development of Alzheimer's disease. In mouse models, long term antibiotic treatment reduced inflammation and the formation of amyloid plaques. However, the reduction was only seen in males. Additionally, the antibiotic treatment altered the activation of microglia in the male mouse models.
Anti-inflammatory medications, such as those commonly prescribed for arthritis, improve depressive symptoms in those with MDD.
Lower doses of the common antibiotic Doxycycline reduces toxicity of alpha synuclein and may be used to help treat Parkinson's disease, a new study reports.